Evidence map›Paper›PMID 31206610›Full record

ArticleClinical pharmacology and therapeutics2019

Democratizing Precision Medicine Through Community Engagement.

Alison E Fohner, Kyle G Volk, Erica L Woodahl

Abstract read
In one paragraph

Article in Clinical pharmacology and therapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Keeping pace withPharmacogenomics · 2022
    Review
  16. Article
  17. Values and Practices to Strengthen Genetic Research Partnerships with Indigenous Communities.Progress in community health partnerships : research, education, and action · 2022
    Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alison E FohnerDepartment of Epidemiology, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-4231-3331
Kyle G VolkDepartment of History, University of Montana, Missoula, Montana, USA.
Erica L WoodahlDepartment of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, Montana, USA.ORCID 0000-0002-0413-4140

Funding

Tracking and Evaluation CoreU54GM115371 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI HOPKINS, SCARLETT H · 2016 to 2020
$20.9M
Vitamin K gene network: Variant discovery and characterizationP01GM116691 · NIGMS · UNIVERSITY OF WASHINGTON · PI THUMMEL, KENNETH E. · 2016 to 2020
$7.6M
Community-engaged Research Toward Precision Medicine with AIAN PeopleR01HG009500 · NHGRI · UNIVERSITY OF ALASKA FAIRBANKS · PI BOYER, BERT BRANDON, DILLARD, DENISE A · 2017 to 2019
$2.0M
NHGRI NIH HHS R01 HG009500NIGMS NIH HHS P01 GM116691NIGMS NIH HHS U54 GM115371
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Community-Institutional RelationsCommunity ParticipationComputational BiologyHealth PrioritiesHealth Services AccessibilityHumansIndians, North AmericanMedically Underserved AreaPharmacogeneticsPrecision MedicineTranslational Research, BiomedicalUniversities

Identifiers

PMID31206610
PMCPMC6692197

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.